Metabolism Drugs Market
According to Intent Market Research, the Metabolism Drugs Market was valued at USD 78.3 billion and will surpass USD 125.3 billion by 2030; growing at a CAGR of 6.9% during 2024 - 2030. The Metabolism Drugs Market is dominated by key players such as, Sanofi, Johnson & Johnson, Merck & Co., Eli Lilly and Company, and Novo Nordisk.